151 related articles for article (PubMed ID: 25621468)
1. Applicability of adipose-derived stem cells in type 1 diabetes mellitus.
Lin HP; Chan TM; Fu RH; Chuu CP; Chiu SC; Tseng YH; Liu SP; Lai KC; Shih MC; Lin ZS; Chen HS; Yeh DC; Lin SZ
Cell Transplant; 2015; 24(3):521-32. PubMed ID: 25621468
[TBL] [Abstract][Full Text] [Related]
2. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.
Jun Y; Kang AR; Lee JS; Park SJ; Lee DY; Moon SH; Lee SH
Biomaterials; 2014 Jun; 35(17):4815-26. PubMed ID: 24636217
[TBL] [Abstract][Full Text] [Related]
3. Adipose Tissue From Type 1 Diabetes Mellitus Patients Can Be Used to Generate Insulin-Producing Cells.
Ikemoto T; Tokuda K; Wada Y; Gao L; Miyazaki K; Yamada S; Saito Y; Imura S; Morine Y; Shimada M
Pancreas; 2020 Oct; 49(9):1225-1231. PubMed ID: 32898009
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Differentiation of Stem Cell-derived Human Pancreatic Progenitors to Treat Type 1 Diabetes.
Maloy MH; Ferrer MA; Parashurama N
Stem Cell Rev Rep; 2020 Dec; 16(6):1139-1155. PubMed ID: 32844324
[TBL] [Abstract][Full Text] [Related]
5. Current progress in stem cell therapy for type 1 diabetes mellitus.
Chen S; Du K; Zou C
Stem Cell Res Ther; 2020 Jul; 11(1):275. PubMed ID: 32641151
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
[TBL] [Abstract][Full Text] [Related]
7. Pdx1-transfected adipose tissue-derived stem cells differentiate into insulin-producing cells in vivo and reduce hyperglycemia in diabetic mice.
Kajiyama H; Hamazaki TS; Tokuhara M; Masui S; Okabayashi K; Ohnuma K; Yabe S; Yasuda K; Ishiura S; Okochi H; Asashima M
Int J Dev Biol; 2010; 54(4):699-705. PubMed ID: 19757377
[TBL] [Abstract][Full Text] [Related]
8. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells.
Godfrey KJ; Mathew B; Bulman JC; Shah O; Clement S; Gallicano GI
Diabet Med; 2012 Jan; 29(1):14-23. PubMed ID: 21883442
[TBL] [Abstract][Full Text] [Related]
9. A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.
Casu A; Trucco M; Pietropaolo M
Pediatr Clin North Am; 2005 Dec; 52(6):1779-804. PubMed ID: 16301093
[TBL] [Abstract][Full Text] [Related]
10. Pluripotent stem cells, a potential source of beta-cells for diabetes therapy.
Hansson M; Madsen OD
Curr Opin Investig Drugs; 2010 Apr; 11(4):417-25. PubMed ID: 20336589
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy and type 1 diabetes mellitus.
Chellappan DK; Sivam NS; Teoh KX; Leong WP; Fui TZ; Chooi K; Khoo N; Yi FJ; Chellian J; Cheng LL; Dahiya R; Gupta G; Singhvi G; Nammi S; Hansbro PM; Dua K
Biomed Pharmacother; 2018 Dec; 108():1188-1200. PubMed ID: 30372820
[TBL] [Abstract][Full Text] [Related]
12. Generation of insulin-producing cells from rat mesenchymal stem cells using an aminopyrrole derivative XW4.4.
Ouyang J; Huang W; Yu W; Xiong W; Mula RV; Zou H; Yu Y
Chem Biol Interact; 2014 Feb; 208():1-7. PubMed ID: 24287272
[TBL] [Abstract][Full Text] [Related]
13. Stem cell therapy to cure type 1 diabetes: from hype to hope.
Chhabra P; Brayman KL
Stem Cells Transl Med; 2013 May; 2(5):328-36. PubMed ID: 23572052
[TBL] [Abstract][Full Text] [Related]
14. Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis.
El-Badawy A; El-Badri N
PLoS One; 2016; 11(4):e0151938. PubMed ID: 27073927
[TBL] [Abstract][Full Text] [Related]
15. Cdc42 Promotes ADSC-Derived IPC Induction, Proliferation, And Insulin Secretion Via Wnt/β-Catenin Signaling.
Xiao XH; Huang QY; Qian XL; Duan J; Jiao XQ; Wu LY; Huang QY; Li J; Lai XN; Shi YB; Xiong LX
Diabetes Metab Syndr Obes; 2019; 12():2325-2339. PubMed ID: 32009808
[TBL] [Abstract][Full Text] [Related]
16. Syngeneically transplanted insulin producing cells differentiated from adipose derived stem cells undergo delayed damage by autoimmune responses in NOD mice.
Tokuda K; Ikemoto T; Yamashita S; Miyazaki K; Okikawa S; Yamada S; Saito Y; Morine Y; Shimada M
Sci Rep; 2022 Apr; 12(1):5852. PubMed ID: 35393479
[TBL] [Abstract][Full Text] [Related]
17. Stem cell therapy for type 1 diabetes mellitus.
Aguayo-Mazzucato C; Bonner-Weir S
Nat Rev Endocrinol; 2010 Mar; 6(3):139-48. PubMed ID: 20173775
[TBL] [Abstract][Full Text] [Related]
18. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
Bhonde RR; Sheshadri P; Sharma S; Kumar A
Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells moderate immune response of type 1 diabetes.
Xv J; Ming Q; Wang X; Zhang W; Li Z; Wang S; Li Y; Li L
Cell Tissue Res; 2017 May; 368(2):239-248. PubMed ID: 27726027
[TBL] [Abstract][Full Text] [Related]
20. [Current status and perspectives of stem cell therapy for the treatment of diabetes mellitus].
Päth G; Seufert J
Med Klin (Munich); 2003 Apr; 98(5):277-82. PubMed ID: 12721673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
